Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Electromed, Inc. stock logo
ELMD
Electromed
$26.53
+0.7%		$36.34
$23.01
▼
$47.40
$220.45M0.4677,930 shs141,419 shs
Outset Medical, Inc. stock logo
OM
Outset Medical
$3.15
+1.6%		$4.14
$3.00
▼
$16.16
$58.27M1.9120,672 shs186,706 shs
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$72.55
+4.4%		$63.26
$23.47
▼
$77.00
$222.55M0.0671,487 shs84,682 shs
Neuronetics, Inc. stock logo
STIM
Neuronetics
$2.90
-2.4%		$2.55
$0.80
▼
$3.44
$226.31M1.161.26 million shs1.12 million shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Electromed, Inc. stock logo
ELMD
Electromed
+0.68%-2.64%-35.09%-31.41%+9.76%
Outset Medical, Inc. stock logo
OM
Outset Medical
+1.61%-1.87%-26.74%-37.62%-77.39%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
+4.43%+15.51%+8.38%+12.71%+121.93%
Neuronetics, Inc. stock logo
STIM
Neuronetics
-2.36%-4.29%-7.64%+135.77%+1.75%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Electromed, Inc. stock logo
ELMD
Electromed
$26.53
+0.7%		$36.34
$23.01
▼
$47.40
$220.45M0.4677,930 shs141,419 shs
Outset Medical, Inc. stock logo
OM
Outset Medical
$3.15
+1.6%		$4.14
$3.00
▼
$16.16
$58.27M1.9120,672 shs186,706 shs
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$72.55
+4.4%		$63.26
$23.47
▼
$77.00
$222.55M0.0671,487 shs84,682 shs
Neuronetics, Inc. stock logo
STIM
Neuronetics
$2.90
-2.4%		$2.55
$0.80
▼
$3.44
$226.31M1.161.26 million shs1.12 million shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Electromed, Inc. stock logo
ELMD
Electromed
+0.68%-2.64%-35.09%-31.41%+9.76%
Outset Medical, Inc. stock logo
OM
Outset Medical
+1.61%-1.87%-26.74%-37.62%-77.39%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
+4.43%+15.51%+8.38%+12.71%+121.93%
Neuronetics, Inc. stock logo
STIM
Neuronetics
-2.36%-4.29%-7.64%+135.77%+1.75%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Electromed, Inc. stock logo
ELMD
Electromed
2.75
Moderate Buy$43.7564.91% Upside
Outset Medical, Inc. stock logo
OM
Outset Medical
2.40
Hold$10.00217.46% Upside
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
3.33
Buy$74.002.00% Upside
Neuronetics, Inc. stock logo
STIM
Neuronetics
2.67
Moderate Buy$4.6760.92% Upside

Current Analyst Ratings Breakdown

Latest OM, STIM, ELMD, and PDEX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/17/2026
Neuronetics, Inc. stock logo
STIM
Neuronetics
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$6.00
9/15/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
9/14/2026
Neuronetics, Inc. stock logo
STIM
Neuronetics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
9/11/2026
Neuronetics, Inc. stock logo
STIM
Neuronetics
B Riley logo
B Riley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy
9/11/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
Ascendiant Capital Markets logo
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$70.00 ➝ $74.00
9/11/2026
Neuronetics, Inc. stock logo
STIM
Neuronetics
B. Riley Financial, Inc. logo
B. Riley Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$5.00
9/9/2026
Neuronetics, Inc. stock logo
STIM
Neuronetics
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$6.00
9/4/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C+) ➝ Buy (B-)
8/26/2026
Electromed, Inc. stock logo
ELMD
Electromed
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$50.00
8/26/2026
Electromed, Inc. stock logo
ELMD
Electromed
Lake Street Capital logo
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$36.00 ➝ $47.00
8/24/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy (B-) ➝ Hold (C+)
(Data available from 9/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Electromed, Inc. stock logo
ELMD
Electromed
$73.78M3.01$0.64 per share41.36$5.10 per share5.20
Outset Medical, Inc. stock logo
OM
Outset Medical
$119.48M0.50N/AN/A$6.99 per share0.45
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$77.55M3.00$4.08 per share17.80$14.92 per share4.86
Neuronetics, Inc. stock logo
STIM
Neuronetics
$149.16M1.48N/AN/A$0.38 per share7.63
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Electromed, Inc. stock logo
ELMD
Electromed
$5.15M$1.3135.37N/AN/A11.34%15.71%13.37%N/A
Outset Medical, Inc. stock logo
OM
Outset Medical
-$81.65M-$4.09N/AN/AN/A-63.06%-61.67%-28.25%11/9/2026 (Estimated)
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$13.66M$4.1317.5721.59N/A17.62%25.13%16.02%10/29/2026 (Estimated)
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$39M-$0.44N/AN/AN/A-19.62%-125.11%-22.15%11/3/2026 (Estimated)

Latest OM, STIM, ELMD, and PDEX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/3/2026Q4 2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$0.67$0.87+$0.20$0.87$19.20 million$20.41 million
8/11/2026Q2 2026
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$0.1230-$0.05+$0.0730-$0.05$40.17 million$41.57 million
8/6/2026Q2 2026
Outset Medical, Inc. stock logo
OM
Outset Medical
-$0.7167-$0.80-$0.0833-$0.97$28.97 million$31.64 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Electromed, Inc. stock logo
ELMD
Electromed
N/AN/AN/AN/AN/A
Outset Medical, Inc. stock logo
OM
Outset Medical
N/AN/AN/AN/AN/A
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/AN/A
Neuronetics, Inc. stock logo
STIM
Neuronetics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Electromed, Inc. stock logo
ELMD
Electromed
N/A
5.10
4.74
Outset Medical, Inc. stock logo
OM
Outset Medical
1.03
5.19
4.11
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
0.28
4.10
2.45
Neuronetics, Inc. stock logo
STIM
Neuronetics
2.84
1.88
1.69

Institutional Ownership

CompanyInstitutional Ownership
Electromed, Inc. stock logo
ELMD
Electromed
40.82%
Outset Medical, Inc. stock logo
OM
Outset Medical
N/A
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
15.28%
Neuronetics, Inc. stock logo
STIM
Neuronetics
53.59%

Insider Ownership

CompanyInsider Ownership
Electromed, Inc. stock logo
ELMD
Electromed
10.50%
Outset Medical, Inc. stock logo
OM
Outset Medical
2.50%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
45.90%
Neuronetics, Inc. stock logo
STIM
Neuronetics
8.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Electromed, Inc. stock logo
ELMD
Electromed
1978.37 million7.36 millionOptionable
Outset Medical, Inc. stock logo
OM
Outset Medical
31018.80 million18.33 millionNot Optionable
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
2063.20 million1.73 millionNot Optionable
Neuronetics, Inc. stock logo
STIM
Neuronetics
65876.20 million69.80 millionOptionable

Recent News About These Companies

BTIG Research Reiterates Buy Rating for Neuronetics (NASDAQ:STIM)
September 17 at 12:53 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-btig-research-reiterates-buy-rating-for-neuronetics-nasdaq-stim-2026-09-17/
Analysts Set Neuronetics, Inc. (NASDAQ:STIM) PT at $4.50
September 16 at 3:14 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31026245
Neuronetics (NASDAQ:STIM) Coverage Initiated at B. Riley Financial
September 13, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31019847
B Riley Securities initiates coverage of Neuronetics at buy
September 12, 2026  |  msn.comhttps://www.msn.com/en-us/money/economy/b-riley-securities-initiates-coverage-of-neuronetics-at-buy/ar-AA2c4hDW
B. Riley Initiates Neuronetics at Buy With $5 Price Target
September 11, 2026  |  marketscreener.comM
Neuronetics (NASDAQ:STIM) Now Covered by B. Riley Financial
September 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-neuronetics-nasdaq-stim-now-covered-by-b-riley-financial-2026-09-11/
Neuronetics, Inc. (NASDAQ:STIM) Receives Average Recommendation of "Moderate Buy" from Brokerages
September 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-neuronetics-inc-nasdaq-stim-receives-average-recommendation-of-moderate-buy-from-brokerages-2026-09-11/
BTIG Research Reaffirms "Buy" Rating for Neuronetics (NASDAQ:STIM)
September 9, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-btig-research-reaffirms-buy-rating-for-neuronetics-nasdaq-stim-2026-09-09/
NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System
September 8, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/08/3357668/0/en/neurostar-advances-practice-innovation-with-first-ever-tms-integration-with-an-ehr-emr-system.html
BlackRock Inc. Invests $776,000 in Neuronetics, Inc. $STIM
September 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-blackrock-inc-invests-776000-in-neuronetics-inc-stim-2026-09-07/
18,540,488 Shares in Neuronetics, Inc. $STIM Purchased by Madryn Asset Management LP
August 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-18540488-shares-in-neuronetics-inc-stim-purchased-by-madryn-asset-management-lp-2026-08-29/
Neuronetics (STIM) Q2 2026 Earnings Call Transcript
August 18, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/neuronetics-stim-q2-2026-earnings-154322384.html
Neuronetics (NASDAQ:STIM) Major Shareholder Acquires 14,000 Shares of Stock
August 18, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-stim-insider-buying-and-selling-2026-08-18/
Neuronetics, Inc. (STIM) Q2 FY2026 earnings call transcript
August 12, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/quote/STIM/earnings/STIM-Q2-2026-earnings_call-660691.html
Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Revenue Growth and Margin Expansion ...
August 12, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/neuronetics-inc-stim-q2-2026-210214027.html
Neuronetics: Q2 Earnings Snapshot
August 11, 2026  |  wtop.comW
Neuronetics Reports Second Quarter 2026 Financial and Operating Results
August 11, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/neuronetics-reports-second-quarter-2026-financial-and-operating-results-1036440611
Neuronetics, Inc. (STIM) Q2 2026 Earnings Call Transcript
August 11, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4934722-neuronetics-inc-stim-q2-2026-earnings-call-transcript
Neuronetics narrows Q2 loss as Greenbrook growth drives 9% revenue increase
August 11, 2026  |  msn.comhttps://www.msn.com/en-us/money/economy/neuronetics-narrows-q2-loss-as-greenbrook-growth-drives-9-revenue-increase/ar-AA29RRR5
Neuronetics (STIM) Reports Q2 Loss, Beats Revenue Estimates
August 11, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2972561/neuronetics-stim-reports-q2-loss-beats-revenue-estimates?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_4-2972561
Neuronetics Reports Second Quarter 2026 Results, Highlights Revenue Growth and Improved Adjusted EBITDA
August 11, 2026  |  quiverquant.comQ

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Illustration of a computer chip on a circuit board with an upward green stock chart line in a server room.
Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
By Thomas Hughes | August 31, 2026
Shoppers browse folded and hanging clothing in a retail apparel store with shelves and racks displayed.
3 Retail Stocks to Watch After a Big Consumer Earnings Week
By Dan Schmidt | August 29, 2026
Data center hallway with rows of server racks and cables, plus a monitoring room with computer screens in the background.
AI Token Costs Are Changing the Hardware vs. Software Debate
By Jeffrey Neal Johnson | September 6, 2026
Trading floor with digital stock displays and workstations, overlaid with the text "S&P 500".
5 Reasons the S&P 500 Could Keep Rallying Through Year-End
By Thomas Hughes | August 20, 2026
A Tesla concept vehicle with illuminated front light bar drives on a road against a city skyline at dusk.
Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
By Sam Quirke | September 8, 2026
Electromed stock logo

Electromed NYSE:ELMD

$26.53 +0.18 (+0.68%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$26.52 -0.01 (-0.02%)
As of 09/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Outset Medical stock logo

Outset Medical NASDAQ:OM

$3.15 +0.05 (+1.61%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$3.12 -0.02 (-0.79%)
As of 09/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Pro-Dex stock logo

Pro-Dex NASDAQ:PDEX

$72.55 +3.08 (+4.43%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$73.00 +0.45 (+0.62%)
As of 09/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

Neuronetics stock logo

Neuronetics NASDAQ:STIM

$2.90 -0.07 (-2.36%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$2.89 -0.01 (-0.45%)
As of 09/18/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas